CT-Based Clinical-Radiomics for Differentiating Talaromyces marneffei Spondylitis From Tuberculous Spondylitis Before Pathogen Confirmation: A Multicentre Diagnostic Study in an Endemic Region.
4 affiliations
- 1Department of Spine and Bone Disease Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
- 2Wuming Hospital of Guangxi Medical University, Nanning, Guangxi, China.
- 3Guangxi Key Laboratory of Extremely Weak Magnetic Field in Cancer Medicine, Nanning, Guangxi, China.
- 4College of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
Abstract
Background
Talaromyces marneffei spondylitis (TMS) is an uncommon but clinically important form of talaromycosis in endemic regions. Where talaromycosis and tuberculosis overlap, TMS may be worked up as tuberculous spondylitis (TBS), delaying fungal investigations and antifungal treatment.Objectives
To assess whether pretreatment CT, routine clinical variables and radiomics features can help differentiate TMS from TBS at the initial assessment stage.Patients/methods
This retrospective multicentre study included 263 patients meeting the prespecified composite reference standard (83 TMS and 180 TBS). Centre A formed the training and internal-validation cohorts; Centres B and C formed the external cohort (n = 50; 16 TMS and 34 TBS). Six clinical variables and 14 CT radiomics features were used to develop clinical, radiomics and combined models.Results
TMS showed a stronger systemic inflammatory phenotype, whereas TBS generally showed more frequent disc-endplate involvement and osseous destruction. The clinical-radiomics model achieved the highest AUCs in the training, internal validation and external validation cohorts: 0.958 (95% CI, 0.924-0.992), 0.940 (95% CI, 0.871-1.000) and 0.927 (95% CI, 0.867-0.987), respectively. The external confidence interval was wide, reflecting the limited external sample size.Conclusions
In regions where talaromycosis and tuberculosis overlap, a pretreatment CT-based clinical-radiomics approach may help flag patients in whom TMS should be considered early. This approach could support earlier fungal investigations while definitive microbiological, molecular or histopathological results are pending. It addresses only the TMS-versus-TBS differential and is not a general spinal-infection triage tool; the findings support further evaluation in endemic settings.
Related
- Adalimumab-induced pustular psoriasis successfully treated with tofacitinib in a patient with ankylosing spondylitis: A brief report.
- GLP-1 receptor agonist initiation and newly recorded ankylosing spondylitis diagnoses in type 2 diabetes: a target trial emulation
- Full-Endoscopic Spine Surgery Enables High Rates of Pathogen Identification after Short-Term Antibiotic Therapy in Pyogenic Spondylitis
- Invasive Pneumococcal Disease Presenting with Pyogenic Spondylitis in a Patient on Chronic Hemodialysis Who Previously Received a Pneumococcal Vaccine
- Case Report: Spinal cord herniation associated with ankylosing spondylitis
BibTeX
@article{zhao2026ctbased,
title = {{CT-Based Clinical-Radiomics for Differentiating Talaromyces marneffei Spondylitis From Tuberculous Spondylitis Before Pathogen Confirmation: A Multicentre Diagnostic Study in an Endemic Region.}},
author = {Xingqi Zhao and Yilin Teng and Gangyi Wu and Rui Huang and Weiliang Liao and Liwei Cheng and Shoufeng Wei and Shaohui Zong and Gaofeng Zeng},
journal = {Mycoses},
year = {2026},
month = oct,
doi = {10.1111/myc.70232},
url = {https://europepmc.org/article/MED/42911174},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - CT-Based Clinical-Radiomics for Differentiating Talaromyces marneffei Spondylitis From Tuberculous Spondylitis Before Pathogen Confirmation: A Multicentre Diagnostic Study in an Endemic Region.
AU - Xingqi Zhao
AU - Yilin Teng
AU - Gangyi Wu
AU - Rui Huang
AU - Weiliang Liao
AU - Liwei Cheng
AU - Shoufeng Wei
AU - Shaohui Zong
AU - Gaofeng Zeng
PY - 2026
DA - 2026/10/01
JO - Mycoses
DO - 10.1111/myc.70232
UR - https://europepmc.org/article/MED/42911174
AB - Background Talaromyces marneffei spondylitis (TMS) is an uncommon but clinically important form of talaromycosis in endemic regions. Where talaromycosis and tuberculosis overlap, TMS may be worked up as tuberculous spondylitis (TBS), delaying fungal investigations and antifungal treatment.Objectives To assess whether pretreatment CT, routine clinical variables and radiomics features can help differentiate TMS from TBS at the initial assessment stage.Patients/methods This retrospective multicentre study included 263 patients meeting the prespecified composite reference standard (83 TMS and 180 TBS). Centre A formed the training and internal-validation cohorts; Centres B and C formed the external cohort (n = 50; 16 TMS and 34 TBS). Six clinical variables and 14 CT radiomics features were used to develop clinical, radiomics and combined models.Results TMS showed a stronger systemic inflammatory phenotype, whereas TBS generally showed more frequent disc-endplate involvement and osseous destruction. The clinical-radiomics model achieved the highest AUCs in the training, internal validation and external validation cohorts: 0.958 (95% CI, 0.924-0.992), 0.940 (95% CI, 0.871-1.000) and 0.927 (95% CI, 0.867-0.987), respectively. The external confidence interval was wide, reflecting the limited external sample size.Conclusions In regions where talaromycosis and tuberculosis overlap, a pretreatment CT-based clinical-radiomics approach may help flag patients in whom TMS should be considered early. This approach could support earlier fungal investigations while definitive microbiological, molecular or histopathological results are pending. It addresses only the TMS-versus-TBS differential and is not a general spinal-infection triage tool; the findings support further evaluation in endemic settings.
SN - 0933-7407
SN - 1439-0507
ER -